Clinical symptoms and courses of primary HIV-1 infection in recent years in Japan

Internal Medicine

Volumn 50, Issue 2, 2011, Pages 95-101

  Nakamura, Hideta ^a   Teruya, Katsuji ^a   Takano, Misao ^a   Tsukada, Kunihisa ^a   Tanuma, Junko ^a   Yazaki, Hirohisa ^a   Honda, Haruhito ^a   Honda, Miwako ^a   Gatanaga, Hiroyuki ^a   Kikuchi, Yoshimi ^a   Oka, Shinichi ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Disease progression; HIV 1; Primary infection

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HOMOSEXUALITY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIMARY HIV 1 INFECTION; PROGNOSIS; RISK ASSESSMENT; SEXUAL INTERCOURSE; SYMPTOMATOLOGY; VIRUS LOAD;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; JAPAN; MALE; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 78751623442     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4137     Document Type: Article

References (25)

1. Collaborative Group on AIDS Incubation and HIV Survival. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative reanalysis. Lancet 355: 1131-1137, 2000.
2. Lyles RH, Munoz A, Yamashita TE, et al. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS cohort study. J Infect Dis 181: 872-880, 2000.
3. Crum-Cianflone N, Eberly L, Zhang Y, et al. Is HIV becoming more virulent? Initial CD4 counts among HIV seroconverters during the course of the HIV epidemic: 1985-2007. Clin Infect Dis 48: 1285-1292, 2009.
4. Muller V, Maggiolo F, Suter F, et al. Increasing clinical virulence in two decades of the Italian HIV epidemic. PLoS Pathog 5: e1000454, 2009.
5. Carrington M, O'Brien SJ. The influence of HLA genotype on AIDS. Annu Rev Med 54: 535-551, 2003.
6. McShane H. Co-infection with HIV and TB: double trouble. Int J STD AIDS 16: 95-100, 2005.
7. Palacios R, Jimenez-Onate F, Aguilar M, et al. Impact syphilis infection on HIV viral load and CD4 cell counts in HIV-infected patients. J Acquir Immun Defic Syndr 44: 356-359, 2007.
8. Duncombe C, Kerr SJ, Ruxrungtham K, et al. HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting. AIDS 28: 169-178, 2005.
9. Pedersen C, Katzenstein T, Nielsen C, et al. Prognostic value of serum HIV-RNA levels at virologic steady state after seroconversion: relation to CD4 cell count and clinical course of primary infection. J Acquir Immune Defic Syndr Hum Retrovirol 16: 93-99, 1997.
10. Vanhems P, Hirschel B, Phillips AN, et al. Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDS. J Infect Dis 182: 334-337, 2000.
11. Vanhems P, Lanbert J, Cooper DA, et al. Severity and prognosis of acute human immunodeficiency virus type 1 illness: a doseresponse relationship. Clin Infect Dis 26: 323-329, 1998.
12. Sterling T, Vlahov D, Astemborski J, et al. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med 344: 720-725, 2001.
13. Henrard DR, Daar E, Farzadegan H, et al. Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 9: 305-310, 1995.
14. Schacker TW, Hughes JP, Shea T, et al. Biological and virologic characteristics of primary HIV infection. Ann Intern Med 128: 613-620, 1998.
15. Lefrere JJ, Roudot-Thoraval F, Mariotti M, et al. The risk of disease progression is determined during the first year of human immunodeficiency virus type 1 infection. J Infect Dis 177: 1541-1548, 1998.
16. Fujiwara M, Tanuma J, Koizumi H, et al. Different abilities of escape mutant-specific cytotoxic T cells to suppress replication of escape mutant and wild-type human immunodeficiency virus type 1 in new hosts. J Virol 82: 138-147, 2008.
17. Tanuma J, Fujiwara M, Teruya K, et al. HLA-A2402-restricted HIV-1 specific T lymphocytes and escape mutation after ART with structured treatment interruptions. Microbes Infect 10: 689-698, 2008.
18. Thompson MA, Aberg JA, Cahn P, et al. Antiretroviral treatment of adult HIV infection; 2010 recommendations of the international AIDS Society-USA Panel. JAMA 304: 321-333, 2010.
19. Goulder PJ, Bunce M, Krausa P, et al. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. AIDS Res Hum Retroviruses 10: 1691-1698, 1996.
20. Kawashima Y, Kuse N, Gatanaga H, et al. Long-term control of HIV-1 in hemophiliacs carrying slow-progressing allele HLA-B5101. J Virol 84: 7151-7160, 2010.
21. Kawashima Y, Pfafferott K, Frater J, et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458: 641-645, 2009.
22. Little SJ, Holte S, Routy JP, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 347: 385-394, 2002.
23. Vanhems P, Lambert J, Cooper DA, et al. Severity and prognosis of acute immunodeficiency virus type 1 illness: a dose-response relationship. Clin Infect Dis 26: 323-329, 1998.
24. Lavreys L, Baeten JM, Chohan V, et al. Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women. Clin Infect Dis 42: 1333-1339, 2006.
25. Goujard C, Bonarek M, Meyer L, et al. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. Clin Infect Dis 42: 709-715, 2006.